Stay updated on Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The changes are limited to UI/layout adjustments and timestamp metadata, while core trial details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T11:39:42.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    4%
    Check dated 2025-10-05T17:24:32.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Updated page to revision v3.1.0 and added current contact details (phones and emails); removed the older v3.0.2 revision.
    Difference
    0.1%
    Check dated 2025-09-28T10:12:36.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Updated release from v3.0.1 to v3.0.2. Removed 'Back to Top' UI element.
    Difference
    0.2%
    Check dated 2025-09-14T00:33:56.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T21:24:10.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new MedlinePlus related topics on brain tumors and skin diseases. Notably, the previous version's references to breast cancer and various pharmacological terms have been removed.
    Difference
    2%
    Check dated 2025-08-30T15:49:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.